Found: 6
Select item for more details and to access through your institution.
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45404-x
- By:
- Publication type:
- Article
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 748, p. 1, doi. 10.1126/scitranslmed.adj4504
- By:
- Publication type:
- Article
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 664, p. 1, doi. 10.1126/scitranslmed.abo5070
- By:
- Publication type:
- Article
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 643, p. 1, doi. 10.1126/scitranslmed.abm3410
- By:
- Publication type:
- Article
Antigenic Site Immunodominance Redirection Following Repeat Variant Exposure.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 6, p. N.PAG, doi. 10.3390/v14061293
- By:
- Publication type:
- Article
Serological Humoral Immunity Following Natural Infection of Children with High Burden Gastrointestinal Viruses.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 10, p. 2033, doi. 10.3390/v13102033
- By:
- Publication type:
- Article